A Double-blinded, Placebo-controlled Study to Evaluate the Tolerability and Efficacy of Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2019
Price : $35 *
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 13 Nov 2019 Status changed from recruiting to completed.
- 29 Apr 2019 Planned End Date changed from 30 May 2019 to 1 Sep 2019.
- 29 Apr 2019 Planned primary completion date changed from 30 Apr 2019 to 29 Jul 2019.